We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

157 hedge funds and large institutions have $379M invested in ANI Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more ownership

Funds ownership: 0% → 54% (+54%)

23% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less capital invested

Capital invested by funds: $399M → $379M (-$19.5M)

8% less funds holding

Funds holding: 170 → 157 (-13)

33% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $9.9M

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
157
Holders Change
-13
Holders Change %
-7.65%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
58
Reduced
47
Closed
25
Calls
$6.65M
Puts
$9.9M
Net Calls
-$3.25M
Net Calls Change
-$3.46M

Top Buyers

1
PA
Perceptive Advisors
New York
+$15.6M
2
GT
Glenmede Trust
Pennsylvania
+$15.1M
3
BFA
BlackRock Fund Advisors
California
+$4.65M
4
Bank of America
Bank of America
North Carolina
+$4.12M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.66M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$9.88M
2
CM
Castleark Management
Illinois
-$6.68M
3
SGAM
Smith Group Asset Management
Texas
-$3.96M
4
BIM
Bogle Investment Management
Massachusetts
-$3.7M
5
MCM
McKinley Capital Management
Alaska
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$3.2M +$70.5K +1,153 +2%
GC
27
Guggenheim Capital
Illinois
$3.12M +$1.95M +31,935 +164%
PRCM
28
Pine River Capital Management
Minnesota
$3.06M – – –
TAM
29
Third Avenue Management
New York
$3.03M -$7.34K -120 -0.2%
1CM
30
1492 Capital Management
Wisconsin
$2.58M +$495K +8,098 +23%
BIM
31
BlackRock Investment Management
Delaware
$2.54M +$441K +7,219 +21%
RHJA
32
Rice Hall James & Associates
California
$2.01M -$12.2K -200 -0.6%
DIA
33
Dana Investment Advisors
Wisconsin
$1.84M +$65.2K +1,067 +4%
JAM
34
JW Asset Management
Florida
$1.8M – – –
New York State Teachers Retirement System (NYSTRS)
35
New York State Teachers Retirement System (NYSTRS)
New York
$1.76M – – –
Morgan Stanley
36
Morgan Stanley
New York
$1.75M -$1.35M -22,085 -43%
Charles Schwab
37
Charles Schwab
California
$1.72M +$94.2K +1,540 +6%
JP Morgan Chase
38
JP Morgan Chase
New York
$1.6M +$972K +15,896 +151%
PVI
39
Pura Vida Investments
New York
$1.59M +$1.61M +26,250 New
LSV Asset Management
40
LSV Asset Management
Illinois
$1.59M +$630K +10,300 +65%
PI
41
Putnam Investments
Massachusetts
$1.47M -$15.2K -249 -1%
Goldman Sachs
42
Goldman Sachs
New York
$1.43M +$672K +10,987 +87%
TCIM
43
TIAA CREF Investment Management
New York
$1.42M -$83.1K -1,359 -5%
Citigroup
44
Citigroup
New York
$1.41M +$871K +14,245 +158%
FSA
45
Franklin Street Advisors
North Carolina
$1.21M -$550K -9,000 -31%
PP
46
Paloma Partners
Connecticut
$1.18M +$1.19M +19,432 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$1.12M -$538K -8,800 -32%
RFC
48
Regions Financial Corp
Alabama
$1.03M +$847K +13,847 +431%
CEP
49
Chicago Equity Partners
Illinois
$1M +$263K +4,300 +35%
Wells Fargo
50
Wells Fargo
California
$995K +$496K +8,118 +98%
1
2
3 4 5

ANIP Hedge Fund Activity: Q4 2016 in Review

157 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2016, worth a combined $379M — down 4.9% from $399M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ANIP and 15 opened new positions — a net loss of 10 holders — while 47 trimmed existing stakes and 58 added.

The largest buyer was Perceptive Advisors, adding an estimated $15.6M. The largest seller was Consonance Capital Management, cutting an estimated $9.88M.

  • 157 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2016, down from 170 in Q3 2016.
  • Funds reported $379M of ANI Pharmaceuticals stock for Q4 2016, down 4.9% quarter-over-quarter.
  • 15 funds opened new ANI Pharmaceuticals positions in Q4 2016 and 25 closed out, a net change of -10 holders.
  • The largest ANI Pharmaceuticals buyer in Q4 2016 was Perceptive Advisors, an estimated $15.6M added.
  • The largest ANI Pharmaceuticals seller in Q4 2016 was Consonance Capital Management, an estimated $9.88M sold.

Based on aggregated 13F filings for Q4 2016.